Home >> News >> Business >> Scar Treatment Market To Reach Worth US$ 35 Bn By 2025

Scar Treatment Market To Reach Worth US$ 35 Bn By 2025

According to the latest report published by Credence Research, Inc. “Scar Treatment Market – Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global scar treatment market was valued at US$ 15.3 Bn in 2016, and is expected to reach US$ 35.0 Bn by 2025, expanding at a CAGR of 9.5% from 2017 to 2025.

The purpose of the report is to illustrate the state of the market of Sterile Injectables, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Browse here for full report: https://www.credenceresearch.com/report/scar-treatment-market

Market Insights

Formation of scar is a typical reaction following any damage or surgery; it is the way the body mends harmed structures. Scar tissue may include just the shallow skin, or it might include the more profound tissues underneath the skin, including nerves and ligaments. The treatment of scar varies accordingly the type and depth of any scar. As per the data obtained from The American Board of Plastic Surgery, in 2016 181,000 procedures were performed only in U.S. which was increased by 1% from 2015.

Increasing incidences of skin disorder due to environmental pollution, radiation is the major driver of the scar treatment market. According to some research study, acne is evaluated to influence around 9.4% of the worldwide population, making it the eighth most common disease around the world. This rising trend of acne due to hormonal imbalance, inappropriate food-habits, and excessive stress positively influence scar treatment market to grow. The increasing adoption of technologically advanced procedures and products, healthcare expenditure for R&D to manufacture newer and innovative products, government approval on medical products, on rising awareness in public to improve physical appearance boost up the growth of scar treatment market. However, the expensive treatment procedures and side effects caused by few treatment procedures are few major challenges associated with the scar treatment market.

The scar treatment market is segmented on the basis of type of scars such as hypertrophic scars, keloid scars, atrophic scars and contractures. Among all the scar types, the atrophic scar is expected to dominate the scar treatment market due to increasing prevalence of acne. On the basis of treatment type the scar treatment market is segmented as surgical treatment, laser treatment, cosmetic treatment, injectable treatment and topical medication. The topical medication holds the major market share whereas laser treatment market is growing and anticipated to face significant growth in forecast period driven by its higher adoption rate and effective treatment procedures.

Based on the end-user types, the scar treatment market can be categorized into hospital, private clinics, drug store or retails store and e-commerce. Hospital segment although dominates the scar treatment market, but private clinic is anticipated to witness significant growth due to rising adoption rate of cosmetic procedure and laser treatment. The e-commerce and retail drug store will also face exponential growth due to high discounts and easy availability.

Geographically, in the year 2016, North America held the major share of scar treatment market followed by Europe. Increasing consciousness about public appearance, adoption of innovative products, increasing expenditure of healthcare to manufacture newer products, rising skin problems drive the market. On the other side, the Asia-Pacific region is assumed to face lucrative growth due to developing healthcare infrastructure and increasing public awareness about health. Asia-Pacific, being the polluted region, there is sharp growth in number of people affected by skin disorders which in turn driving the growth of scar treatment market.

Market Competition Assessment:

The scar treatment market comprises of numerous companies having their products marketed. However, most of the companies are located in the North America and others developed regions. The companies have untapped opportunities in the developing regions of Asia Pacific and Latin America. Companies are coming up with various products in the developed nations due to high acceptance and accessibilities of these products. The companies include Smith & Nephew plc., Lumenis, Sonoma Pharmaceuticals, Inc., Scarheal Inc., CCA Industries, Inc., Cynosure, Inc., Syneron Medical Ltd., Mölnlycke Health Care AB, Beijing Toplaser Technology Company Ltd., Merz GMBH & Co KGAA, Valeant Pharmaceuticals International Inc., Quantum Health, Hologic Inc. and others.

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Sterile Injectables buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Scar Treatment contains:

Analysis and forecast of Sterile Injectables market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Sterile Injectables market;

Assessment and forecast of Sterile Injectables market development;

Financial and business profiles of the leading companies in the Sterile Injectables industry.

Scope

– Up to date working Sterile Injectables data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Sterile Injectables for the period 2018 to 2026

– Planned Sterile Injectables additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Sterile Injectables projects by region, key countries, and companies

– Details of major planned Sterile Injectables projects in the world up to 2026

Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58671

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *